Simplicity Wealth LLC Has $226,000 Stock Position in HCA Healthcare, Inc. $HCA

Simplicity Wealth LLC reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 78.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 485 shares of the company’s stock after selling 1,790 shares during the period. Simplicity Wealth LLC’s holdings in HCA Healthcare were worth $226,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Palisade Asset Management LLC acquired a new stake in shares of HCA Healthcare during the third quarter worth $26,000. Holos Integrated Wealth LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $29,000. Ares Financial Consulting LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $31,000. JPL Wealth Management LLC acquired a new stake in shares of HCA Healthcare during the third quarter worth $33,000. Finally, Aventura Private Wealth LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $34,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA stock opened at $433.73 on Monday. The stock has a market capitalization of $96.22 billion, a P/E ratio of 14.92, a P/E/G ratio of 1.37 and a beta of 1.18. The business has a 50-day moving average of $497.66 and a 200-day moving average of $486.41. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period in the prior year, the company earned $6.45 earnings per share. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 30.05 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is 10.73%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on HCA shares. TD Cowen decreased their price objective on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, April 27th. Wells Fargo & Company reduced their target price on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a report on Monday, April 27th. Argus lifted their target price on HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a report on Friday, February 6th. Leerink Partners reduced their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, Oppenheimer reduced their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $520.55.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the sale, the executive vice president owned 8,853 shares in the company, valued at $4,721,924.61. This represents a 16.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 15,214 shares of company stock valued at $7,797,595. 1.50% of the stock is currently owned by company insiders.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.